Square Circle Brokers

Square Circle Brokers Limited

ActiveLatest figures: 2023Abridged accountsCompany only16 years on the register

Private limited company registered in London, classed under “Non-life insurance”.

Headline figures

FY to Jan 2023 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

3 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

Pro

Every figure for all 3 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

From the filed balance sheets · £

Balance sheet	2021	2022	2023
Current assets
of which debtors
of which cash
Creditors due within a year
Net current assets
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year
Cash ratioCash for every £1 owed within a year
Creditors to assetsEverything owed to creditors as a share of fixed plus current assets

6 balance-sheet lines and 3 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

›What does Square Circle Brokers do?

Private limited company registered in London, classed under “Non-life insurance”.

›How much turnover does Square Circle Brokers make?

Answered in the full report

›Is Square Circle Brokers profitable?

Square Circle Brokers's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Square Circle Brokers?

Answered in the full report

›Where is Square Circle Brokers based?

Its registered office is 7th Floor Corn Exchange, 55 Mark Lane, London, EC3R 7NE, in London.

›When was Square Circle Brokers founded?

Square Circle Brokers Limited was incorporated on 15 January 2010.

›Is Square Circle Brokers still trading?

The register lists Square Circle Brokers Limited as active.